Clinical experience of thoracoplasty with absorbable rib substitutes
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · Mar 2023 · 1 min read
In brief
In brief
This case series describes successful thoracoplasty using absorbable rib substitutes (BioBridge®) in three pediatric patients with malignant chest wall tumors. The technique achieved negative resection margins, good cosmetic outcomes, and preserved chest wall flexibility without interfering with radiotherapy, offering a promising alternative for pediatric chest wall reconstruction.
Written by the GCMD Library team from the article.
Abstract
Purpose
Malignant chest wall tumors are rare in pediatrics. They require multimodal oncological treatment and local surgical control. Resections are extensive; therefore, thoracoplasty should be planned to protect intrathoracic organs, prevent herniation, future deformities, preserve ventilatory dynamics, and enable radiotherapy.
Methods
We present a case series of children with malignant chest wall tumors and our surgical experience with thoracoplasty using absorbable rib substitutes (BioBridge®), after local surgical control. BioBridge® is a copolymer made of a polylactide acid blend (70% L-lactic acid y 30% DL-lactide).
Results
In 2 years, we had three patients with malignant chest wall tumors. Resection margins were negative, without recurrence at follow-up. We achieved good cosmetic and functional results, and no postoperative complications.
Conclusion
Alternative reconstruction techniques such as absorbable rib substitutes provide protection, guarantee a flexible chest wall, and do not interfere with adjuvant radiotherapy. Currently, there are no management protocols in thoracoplasty. This option represents an excellent alternative for patients with chest wall tumors. Knowledge of different approaches and reconstructive principles is essential to offer children the best onco-surgical option.